Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Issuances Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Receivables - Other Shares Issued Shares Outstanding Shares Outstanding Shares Repurchased

Rockwell Medical (RMTI) Long-Term Debt Repayments (2019 - 2026)

Rockwell Medical filings provide 12 years of Long-Term Debt Repayments readings, the most recent being $198000.0 for Q4 2025.

On a quarterly basis, Long-Term Debt Repayments fell 1.49% to $198000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $664000.0, a 2.79% increase, with the full-year FY2025 number at $664000.0, up 2.79% from a year prior.
Long-Term Debt Repayments hit $198000.0 in Q4 2025 for Rockwell Medical, roughly flat from $198000.0 in the prior quarter.
In the past five years, Long-Term Debt Repayments ranged from a high of $3.0 million in Q2 2022 to a low of -$5.3 million in Q4 2022.
Median Long-Term Debt Repayments over the past 5 years was $244000.0 (2024), compared with a mean of $366866.7.
Biggest five-year swings in Long-Term Debt Repayments: skyrocketed 198.3% in 2021 and later plummeted 807.6% in 2022.
Rockwell Medical's Long-Term Debt Repayments stood at $750000.0 in 2021, then plummeted by 807.6% to -$5.3 million in 2022, then soared by 123.59% to $1.3 million in 2023, then plummeted by 83.95% to $201000.0 in 2024, then fell by 1.49% to $198000.0 in 2025.
The last three reported values for Long-Term Debt Repayments were $198000.0 (Q4 2025), $198000.0 (Q3 2025), and $67000.0 (Q2 2025) per Business Quant data.